TABLE 1.
Baseline characteristics of 92 patients with interim PET‐guided therapy.
| All eligible n = 92 | Interim PET‐positive n = 19 | Interim PET‐negative n = 73 | |
|---|---|---|---|
| n (%) | n (%) | n (%) | |
| Median age, years (IQR) | 35 (28–48) | 27 (24–44) | 35 (30–49) |
| Gender male | 53 (58) | 8 (42) | 45 (62) |
| ECOG‐PS | |||
| 0/1 | 87 (95) | 17 (89) | 70 (96) |
| 2 | 5 (5) | 2 (11) | 3 (4) |
| Ann Arbor stage | |||
| III/IV | 83 (90) | 17 (89) | 66 (90) |
| IIB | 9 (10) | 2 (11) | 7 (10) |
| B symptom (+) | 51 (55) | 11 (58) | 40 (55) |
| Maximum tumor diameter | |||
| Less than 5 cm | 49 (53) | 5 (26) | 44 (60) |
| 5 cm or more, but less than 10 cm | 28 (30) | 8 (42) | 20 (27) |
| 10 cm or more | 15 (16) | 6 (32) | 9 (12) |
| Bulky mediastinal lesion (+) | 14 (15) | 6 (32) | 8 (11) |
| International prognostic score | |||
| 0–3 | 63 (68) | 12 (63) | 51 (70) |
| 4–7 | 29 (32) | 7 (37) | 22 (30) |
| Eligible by pathological central review | 89 (97) | 19 (100) | 70 (96) |